BRD-K69726595-001-01-2 (Substance)

Compound:

mericitabine

Synonyms:BRD-K69726595-001-01-2

Id:340084909

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View BRD-K69726595-001-01-2's neighborhood in the knowledge graph.

Submit

Results found

Linked to

	Label	Description
	L1000 LINCS DCIC 2021 REP.B023 MCF7 24H G09 mericitabine 0.25uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC REP.A023 A375 24H G09 mericitabine 1.11um Biosample (Entity type)	A biosample from LINCS produced as part of the L1000 Phase2 project
	L1000 LINCS DCIC 2021 REP.A023 MDAMB231 24H G07 mericitabine 10uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC REP.A023 HELA 24H G07 mericitabine 10.00um Biosample (Entity type)	A biosample from LINCS produced as part of the L1000 Phase2 project
	L1000 LINCS DCIC 2021 REP.A023 HELA 24H G12 mericitabine 0.04uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 REP.B023 MDAMB231 24H G11 mericitabine 0.03uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 REP.B023 A375 24H G08 mericitabine 0.74uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 REP.B023 THP1 24H G12 mericitabine 0.01uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC REP.A023 HT29 24H G11 mericitabine 0.12um Biosample (Entity type)	A biosample from LINCS produced as part of the L1000 Phase2 project
	L1000 LINCS DCIC 2021 REP.A023 YAPC 24H G10 mericitabine 0.37uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project